Connect Compass Insights Discovery
Connect
Veridata Connect
Integrate any system. Harmonize any format.

Your clinical, genomic, and real-world data lives in dozens of systems: EHRs, LIS, LIMS, sequencing platforms, biobanks, claims databases. Connect brings them together without migration, without downtime, and without surrendering your data to a third party.

Raw data is progressively harmonized through validation, deduplication, and linking to a unified patient record. Every transformation is logged, every source is traceable, and every format is supported. For lab partners: one integration point to reach all your customers. For customers: one connection to access all your labs.

Who it's for Diagnostic labs scaling customer integrations. Health systems consolidating lab partners into one connection. Cancer centers unifying EHR and molecular data. BioPharma integrating multi-site trial data.
VCF
HL7 v2.x
FHIR R4
mzML / imzML
EDI / Claims
1
Parse
Format auto-detected. 15 raw variants extracted. 3 fail quality. 12 pass.
2
Validate & Enrich
8 meet VAF threshold. +HGVS. +gnomAD. +ClinVar. QC evaluated.
3
Classify & Code
AMP/ASCO/CAP: Tier I: 1 · II: 2 · III: 5. CPT + ICD-10 assigned.
4
Resolve Patient
Patient matched. Confidence: 0.95. MRN confirmed. No conflicts.
EHR
LIS
LIMS
FHIR Bundle
Governed · Coded · Signed · Lineage traced
Ingestion

Multi-Protocol Gateway

FHIR R4, HL7 v2.x, REST webhooks, streaming interfaces, file upload, and custom connectors. Automatic format detection validates data on arrival. No manual mapping for standard formats.

Resolution

Patient Identity & Routing

Automated patient matching across disparate source systems. Deterministic and probabilistic matching with configurable confidence thresholds. Order routing across lab partners, result delivery, and care coordination. Unified canonical data model with tenant-level isolation.

Translation

Schema Harmonization

AI-assisted field mapping with synonym detection. Multi-modal parser handles genomics (VCF), clinical (FHIR, HL7), research (CDISC), proteomics, spatial transcriptomics, and metabolomics.

Compass
Veridata Compass
From variant to therapy. Governed and traceable.

Compass is the clinical intelligence engine at the core of Veridata OS. It takes harmonized patient data and runs it through composable pipelines: variant classification, therapy matching, trial screening, contraindication checking, and evidence assembly. Complete provenance on every step.

Every pipeline produces reproducible execution by default. Identical inputs produce identical outputs, provably. For borderline cases where the evidence is ambiguous, Compass engages cognitive reasoning with confidence scoring and full audit trails. The boundary between deterministic and cognitive execution is configurable per tenant, per step.

Who it's for Lab directors automating variant reporting. Oncologists matching patients to therapies and trials. Compliance teams requiring 21 CFR Part 11 audit trails.
EGFR L858R
TP53 R248W
PD-L1 45%
1
Classify Variants
AMP/ASCO/CAP tiering. EGFR L858R → Tier I.
CIViC
ClinVar
OncoKB
2
Match Therapies
3 matched. Osimertinib (Level A). Interactions checked.
OpenFDA
PharmGKB
3
Screen Trials
2 eligible. Eligibility criteria evaluated across open trials.
ClinicalTrials.gov
gnomAD
Confidence: 0.72 → Cognitive reasoning activated · evidence ambiguity detected
4
Assemble Evidence
Evidence bundle signed. 21 CFR Part 11 compliant.
Audit Log
Golden Thread
Every output traces back through every step, every knowledge source, every decision. Full execution lineage from variant to clinical action.
✓ 3 Therapies
✓ 2 Trials
⚠ 1 Contraindication
Deterministic · Signed · Versioned · Auditable
Engine

Composable Pipelines

Clinical workflows spanning variant classification, therapy matching, trial eligibility, screening programs, and revenue cycle. Each step produces a signed, versioned output. Retry any step, cascade downstream.

Knowledge

Context Graph

Real-time enrichment from CIViC, ClinVar, ClinicalTrials.gov, OncoKB, gnomAD, PharmGKB, and more. Always returns an answer: live data when available, curated evidence as baseline. Every source tagged for provenance.

Reasoning

Cognitive Architecture

LLM-enhanced reasoning activates when deterministic rules produce low-confidence results. Confidence scoring, evidence weighting, and reasoning traces. All auditable, with deterministic fallback guaranteed.

Insights
Veridata Insights
Ask questions. Get governed answers.

Insights turns your data warehouse into a conversational interface. Ask questions in natural language about cohort sizes, billing trends, variant frequencies, or trial performance, and get governed answers with signed execution history.

Every query is translated into validated analytical logic, executed against your data, and returned with lineage showing exactly how the answer was derived. No black-box AI. No hallucinated numbers. Your data, your warehouse, governed answers.

Who it's for Data scientists building research cohorts. Revenue cycle teams tracking denial rates. Clinical operations teams monitoring screening compliance.
Find all participants with BRCA1 or BRCA2 mutations
26,132
Patients
11
Cancer Types
9,261
Actionable
56 rows · v_variant_classifications · 5.2s
How many are eligible for clinical trials?
3
Active Trials
752
Eligible
100%
Actionable
v_trial_matches · computed join · 1.6s
Show ctDNA surveillance: rising, stable, or declining?
64,381
Patients
4,508
Rising
Rising 7% Stable 41% Declining 12%
156,458 measurements · classified at query time · 0.8s
Eleanor Chen → Generate clinical report
Classify
Match
Screen
Assemble
EGFR L858R → Tier I · 3 therapies · 2 trials · lineage signed
500K patients · 4 prompts · Every answer governed and traceable
Show Lynch syndrome screening gaps across the biobank
26,132
Tested
977
Lynch+
3.7%
Positive Rate
MSI-H + MMR loss · v_screening_gaps · 3.1s
Show MRD enrollment compliance
2,500
Enrolled
200
Overdue
14
Positive Pending
v_mrd_compliance · enrollment + draw schedule · 1.2s
Billing denial rate by test and payer?
13.6%
Denial Rate
$199M
Charged
$108M
Collected
65,239 claims · v_billing_summary · ctDNA assay highest at 23%
Analyze revenue cycle for ctDNA monitoring
Econ
Coverage
Denials
Reimb
Revenue
$4.2M coverage gaps · 412 appealable · 16.5x ROI on fix
Same interface · Clinical + operational queries · One platform
Analytics

Natural Language Engine

Ask in plain English, get structured results. Supports clinical, financial, operational, and research queries. Every answer traced back to the underlying data and logic.

Discovery

Cohort & Population

Build patient cohorts with multi-dimensional filtering: demographics, variants, diagnoses, treatments, trial eligibility, screening status. Real-time population-level views from your own data.

Revenue

Financial Analytics

Billing summaries, denial rates, payer coverage analysis, test economics. From claim generation to appeal letter drafting, all governed by the same audit infrastructure as clinical workflows.

Discovery
Veridata Discovery
Multi-omic intelligence. Bench to bedside.

Discovery extends Veridata OS into the research and translational space. Genomic, proteomic, and functional response pipelines on a single platform. Parse, annotate, and correlate across modalities with complete provenance from sample to insight.

Built for translational teams bridging the gap between bench research and clinical application. GPU-accelerated workflows with planned NVIDIA Parabricks and BioNeMo integration. Every result traceable from raw data through analysis to clinical interpretation.

Who it's for Translational research teams. Biobank operators. BioPharma R&D groups running multi-omic studies.
Genomics
VCF parsing, variant calling, AMP/ASCO/CAP classification. QC metrics, coverage, concordance.
Parabricks
BioNeMo
Proteomics
Spatial transcriptomics, metabolomics parsing. pQTL correlation. Protein-cancer risk scoring.
AlphaFold
MONAI
Drug Screen
Functional Response
Organoid drug sensitivity, IC50 computation. Therapy prediction from functional data.
Drug Screen
ChEMBL
Cross-Modal Correlation
EGFR L858R genomic + protein overexpression → therapy response predicted
MET amp + organoid resistance confirmed → alternative pathway identified
pQTL link: APOE variant → protein level shift → cancer risk score updated
GPU-accelerated · Full lineage · Sample to insight
Genomics

Variant Pipelines

VCF parsing, variant calling, AMP/ASCO/CAP classification. QC metrics, coverage analysis, concordance scoring across platforms. GPU-accelerated via NVIDIA Parabricks.

Proteomics

Multi-Omic Integration

Proteomics, spatial transcriptomics, metabolomics parsing and normalization. pQTL and protein-cancer risk correlation. Cross-modal biomarker discovery.

Functional

Drug Response Modeling

Organoid drug sensitivity screening, IC50 computation, therapy prediction. Correlate functional response with genomic variants for precision treatment selection.

Veridata Composer
See it in action
Veridata Composer — clinical pipeline with variant classification, therapy matching, and trial screening
Clinical pipeline: variant classification, therapy matching, trial eligibility
Veridata Composer — ctDNA surveillance analytics with signal classification
ctDNA surveillance: 64K patients, signal classification
Veridata Composer — natural language data query with BRCA mutation results
Natural language query: BRCA1/BRCA2 cohort identification
Get Started
Ready to own your precision medicine infrastructure?
See how Connect, Compass, and Insights work with your data.
Schedule a demo